Programme
Scientific Programme 
Thursday, January 30, 2020
Opening Talk
| Time | Presentation Title | Speaker |
| 08:30-09:00 | Opening and Objectives | Jolanta Kunikowska, Ken Herrmann |
Thursday, January 30, 2020
Imaging of NET
Chairpersons: J. Kunikowska / M. Pavel / R. J. Hicks
| Time | Presentation Title | Speaker |
| 09:00-09:25 | Clinical and Biochemical Signs of NET | Marianne Pavel |
| 09:30-09:55 | Contribution of Radiology for NET Imaging | Anders Sundin |
| 10:00-10:25 | Contribution of Nuclear Medicine for NET Imaging | Valentina Ambrosini |
| 11:00-11:05 | Controversy: Is there still a Role of Somatostatine Receptor Scintigraphy in NET? | Kjell Öberg |
| 11:05-11:25 | In Favour | Rodney John Hicks |
| 11:25-11:45 | Against | Val Lewington |
| 11:45-12:00 | Discussion | all |
| 12:00-13:00 | Consensus on Imaging of NET | David Taïeb |
Thursday, January 30, 2020
Imaging and Therapy of Pheochromocytoma and Paraganglioma
Chairpersons: K. Herrmann / D. Taïeb / W. de Herder
| Time | Presentation Title | Speaker |
| 14:00-14:25 | Clinical, Biochemical and Genetic Behavior of Pheochromocytoma and Paraganglioma | Aldo Scarpa |
| 14:30-14:55 | Contribution of Nuclear Medicine for Pheochromocytoma and Paraganglioma | David Taïeb |
| 15:00-15:25 | Place of Radionuclide Therapy in Pheochromocytoma and Paraganglioma | Irene Virgolini |
| 16:00-16:05 | Controversy: Is there a Space for MIBG-Imaging and Therapy? | Eric Baudin |
| 16:05-16:25 | In Favour | Val Lewington |
| 16:25-16:45 | Against | Irene Virgolini |
| 16:45-17:00 | Discussion | all |
| 17:00-18:00 | Consensus on Imaging and Therapy of Pheocromocytoma and Paraganglioma | Wouter de Herder |
Friday, January 31, 2020
PRRT of NET
Chairpersons: J. Kunikowska / L. Bodei / J. Strosberg
| Time | Presentation Title | Speaker |
| 09:00-09:25 | Current State of PRRT | Lisa Bodei |
| 09:30-09:55 | Is Dosimetry Needed for Each Patient? | Marta Cremonesi |
| 10:00-10:25 | Ongoing Studies | Eric Baudin |
| 11:00-11:05 | Controversy: Kinase Inhibitor or PRRT, Which First? | Jonathan Strosberg |
| 11:05-11:25 | PRRT First | Levent Kabasakal |
| 11:25-11:45 | Kinase Inhibitor First | James C. Yao |
| 11:45-12:00 | Discussion | all |
| 12:00-13:00 | Consensus on PRRT of NET | Jonathan Strosberg |
Friday, January 31, 2020
Treatment Monitoring
Chairpersons: K. Herrmann / K. Öberg / G. Kaltsas
| Time | Presentation Title | Speaker |
| 14:00-14:25 | Definition of Progression in NET Patient: Clinical, Biochemical, Imaging | Gregory Kaltsas |
| 14:30-14:55 | Contribution of Radiology for Treatment Monitoring | Clarisse Dromain |
| 15:00-15:25 | Contribution of Nuclear Medicine for Treatment Monitoring | Damian Wild |
| 16:00-16:05 | Controversy: Are RECIST Criteria Appropriate for Monitoring Response of PRRT? | Massimo Falconi |
| 16:05-16:25 | In Favour | Anders Sundin |
| 16:25-16:45 | Against | Kjell Öberg |
| 16:45-17:00 | Discussion | all |
| 17:00-18:00 | Consensus on Treatment Monitoring | Massimo Falconi |
Saturday, February 1, 2020
Look into the Future
Chairpersons: K. Herrmann / R. J. Hicks / M. Fani
| Time | Presentation Title | Speaker |
| 09:00-09:25 | New Radiotracers for Imaging and Therapy | Melpomeni Fani |
| 09:30-09:55 | Current Trial with New Tracer (Excendin, CXCR4, Antagonist) | Damian Wild |
| 10:00-10:20 | NET Test | Lisa Bodei |
| 11:00-11:20 | PRRT in New Version (Intraarterial Administration, Alpha Emitters) | Marta Cremonesi |
| 11:20-11:40 | Combination Treatment PRRT + Chemotherapy | Rodney John Hicks |
| 11:40-12:00 | Combination Treatment PRRT + Immunotherapy | James C. Yao |
| 12:00-12:20 | Life with NET | Catherine Bouvier |
| 12:20-12:45 | Discussion | all |
| 12:45-13:00 | Future Directions & Closing Remarks | Jolanta Kunikowska Ken Herrmann |